273 results
Page 2 of 14
8-K
EX-2.2
9t6539ep 1dgm
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
lrthhj4exvo6thtyi bp
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
sx1f08b9es jd8s83
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
l0d rrlnf4yit3
23 Mar 22
Business combination disclosure
5:29pm
425
gxtn5tjxzc0
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
wbtts0mfr
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
ljloe8 2y1r
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
rqxexmeo
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
qqk osd2lagf
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
y88se5qoc2vasa02
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
f33xnc4iwfp2g4j dhk
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
62i52kxpu4eyrfr0d
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
zm8oh
13 Oct 20
Entry into a Material Definitive Agreement
8:44am